Reuters logo
BRIEF-Oasmia Q4 operating loss widens
June 8, 2017 / 6:53 AM / 6 months ago

BRIEF-Oasmia Q4 operating loss widens

June 8 (Reuters) - Oasmia Pharmaceutical Ab:

* Q4 consolidated net sales amounted to 44,000 SEK compared to 59,000 in q4 previous year

* Q4 operating loss was 37 mln SEK compared to a loss of 31 mln SEK in q4 previous year

* Says the board does not intend to propose any dividends for the financial year May 1, 2016 – April 30, 2017. Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below